Abstract:Infections caused by multidrug-resistant bacteria have emerged in recent decades, leading to escalating interest in host defense peptides (HDPs) to reverse this dangerous trend. Inspired by the modular design in bioengineering, herein we report a new class of small amphiphilic scorpionlike peptidomimetics based on this strategy. These HDP mimics show potent antimicrobial activity against both Gram-positive and Gram-negative bacteria without drug resistance but with a high therapeutic index. The membrane-compromising action mode was suggested to be their potential bactericidal mechanism. Pharmacodynamic experiments were conducted using a murine abscess model of methicillin-resistant Staphylococcus aureus (MRSA) infections. The lead compound 12 showed impressive in vivo therapeutic efficacy with ∼99.998% (4.7log) reduction in skin MRSA burden, a significantly higher bactericidal efficiency than ciprofloxacin, and good biocompatibility. These results highlight the potential of these HDP mimics as novel antibiotic therapeutics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00312?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00312</a>.Time-kill kinetics of compound 12 and ciprofloxacin against E. coli; E. coli biofilm inhibition by compound 12; drug resistance study of compound 12 against E. coli; and 1H NMR, 13C NMR, and HPLC trace information (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00312/suppl_file/jm1c00312_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00312/suppl_file/jm1c00312_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Human defensin-inspired discovery of peptidomimetic antibiotics

Recent advances in the research and development of human defensins.

[Advances in the Research of Human Defensins].

Self-Assembling Myristoylated Human Α-Defensin 5 As a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection.

Defensins: The natural peptide antibiotic

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Human alpha-defensin 5 variant and uses thereof

Mining the bacterial genome to discover new antimicrobial molecules

Challenges in the development of next-generation antibiotics: opportunities of small molecules mimicking mode of action of host-defense peptides

A Simplified Derivative of Human Defensin 5 with Potent Efficiency against Multidrug-resistant Acinetobacter baumannii.

Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide

Production and characterization of recombinant human beta-defensin DEFB120.

Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Modular Design of Membrane-Active Antibiotics: From Macromolecular Antimicrobials to Small Scorpionlike Peptidomimetics

Sa.84. Α-Defensins Inhibit Interleukin-1β Production

173 Human Defensins - Small in Size but Big in Functionality

Human Defensins: Turning Defense into Offense?

Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria

High-Throughput Screening for Epigenetic Compounds That Induce Human β-Defensin 1 Synthesis

Developments with investigating descriptors for antimicrobial AApeptides and their derivatives

The Development of Antimicrobial A-Aapeptides That Suppress Proinflammatory Immune Responses.